# MDGA2

## Overview
MDGA2 is a gene that encodes the protein MAM domain containing glycosylphosphatidylinositol anchor 2, which is a member of the immunoglobulin superfamily. This protein is characterized by its structural composition, including six immunoglobulin-like domains and a conserved MAM domain, and is anchored to the cell membrane via a glycosylphosphatidylinositol (GPI) anchor (Litwack2004Identification). MDGA2 plays a crucial role in neural development and synaptic transmission, primarily through its involvement in cell adhesion and synaptic modulation. It interacts with key synaptic proteins, such as neuroligins and NMDA receptor subunits, influencing synaptic plasticity and connectivity (Connor2016Altered; Bemben2023Contrasting). The protein's regulatory functions are significant in maintaining the excitatory/inhibitory balance in the brain, and its dysregulation has been linked to neurological disorders such as autism spectrum disorders and schizophrenia (Connor2016Altered; Bemben2023Contrasting). Additionally, MDGA2 has been implicated in cancer biology, particularly as a tumor suppressor in gastric cancer, where it interacts with DNA methyltransferase 1 associated protein 1 (DMAP1) to modulate cell proliferation and apoptosis (Wang2015MDGA2).

## Structure
MDGA2 is a protein that belongs to the immunoglobulin superfamily and is characterized by a unique structural organization. The primary structure of MDGA2 includes 956 amino acids, with a domain organization consisting of six immunoglobulin (Ig)-like domains followed by a highly conserved MAM domain (Litwack2004Identification). Unlike its homolog MDGA1, MDGA2 lacks a fibronectin type III (FnIII) domain (Litwack2004Identification). 

The protein is highly glycosylated, which is a common post-translational modification that affects its molecular weight (Litwack2004Identification). MDGA2 is anchored to the cell membrane via a glycosylphosphatidylinositol (GPI) anchor, indicating its role in cell adhesion processes (Litwack2004Identification). 

MDGA2 can engage in homophilic interactions, which are crucial for its function in axonal growth, as demonstrated by its ability to self-aggregate in cell aggregation assays (Joset2011Rostral). The protein is expressed in multiple splice variant isoforms, which may arise from alternative polyadenylation (Litwack2004Identification). These structural features suggest that MDGA2 plays a significant role in neural development and synaptic transmission.

## Function
MDGA2 is a protein involved in various molecular processes, primarily in the brain, where it plays a significant role in synaptic development and function. It is associated with both excitatory and inhibitory synapses, interacting with NMDA receptor subunits such as GluN1, GluN2A, and GluN2B, which suggests its involvement in synaptic transmission and plasticity (Bemben2023Contrasting). MDGA2 modulates synaptic interactions by binding to neuroligins (NL1 and NL2), inhibiting their interaction with neurexins, which is crucial for synapse formation. This regulatory function affects both excitatory and inhibitory synapse density, impacting synaptic transmission and connectivity (Connor2016Altered).

In the context of cell biology, MDGA2 is involved in cell adhesion and signaling pathways, influencing neuronal connectivity and plasticity. It suppresses excitatory synapse development, maintaining a balance in synaptic transmission, which is essential for normal cognitive functions and neural circuit formation (Connor2016Altered). MDGA2's role in synaptic regulation is crucial for maintaining the excitatory/inhibitory balance in the brain, and its dysregulation has been linked to conditions such as autism spectrum disorders (Connor2016Altered).

## Clinical Significance
MDGA2 is implicated in several diseases due to mutations or alterations in its expression. In gastric cancer, MDGA2 acts as a tumor suppressor, and its expression is often silenced or downregulated due to promoter hypermethylation. This silencing is associated with increased tumor growth, poor survival outcomes, and is an independent prognostic factor for poor survival in gastric cancer patients (Wang2015MDGA2). MDGA2's tumor suppressive effects are partly mediated through its interaction with DMAP1, which stabilizes DMAP1 by inhibiting its ubiquitin-mediated degradation, contributing to the suppression of tumor growth (Wang2015MDGA2).

In the context of neurological disorders, MDGA2 is associated with autism spectrum disorders (ASD) and schizophrenia. It plays a role in regulating synaptic transmission, particularly at inhibitory synapses, and its dysfunction is linked to these conditions (Bemben2023Contrasting). MDGA2 interacts with neuroligin-2, influencing GABAergic transmission, which is crucial for maintaining synaptic balance. Alterations in MDGA2 expression or function can disrupt this balance, contributing to the pathophysiology of neurodevelopmental disorders (Zeppillo2024Functional; Bemben2023Contrasting).

## Interactions
MDGA2 interacts with several proteins, playing a significant role in both neural development and cancer biology. In the nervous system, MDGA2 is known to interact with neuroligins, particularly neuroligin-2 (NL2), where it acts as a negative regulator of synapse development by blocking neuroligin-neurexin interactions. This interaction is crucial for modulating synaptic adhesion and signaling, influencing synaptic plasticity and potentially contributing to neurodevelopmental disorders (Connor2019Pumping).

In the context of gastric cancer, MDGA2 interacts with DNA methyltransferase 1 associated protein 1 (DMAP1). This interaction is significant for its tumor suppressive functions. MDGA2 stabilizes DMAP1 by inhibiting its ubiquitin-mediated degradation, which leads to increased levels of DMAP1. This stabilization is crucial for the activation of the p53/p21 signaling cascade, which induces apoptosis and inhibits cell proliferation in gastric cancer cells (Wang2015MDGA2). The interaction between MDGA2 and DMAP1 has been confirmed through co-immunoprecipitation and GST pull-down assays, highlighting the specificity and importance of this interaction in cancer biology (Wang2015MDGA2).


## References


[1. (Zeppillo2024Functional) Tommaso Zeppillo, Heba Ali, Sowbarnika Ravichandran, Tamara C. Ritter, Sally Wenger, Francisco J. López-Murcia, Erinn Gideons, Janetti Signorelli, Michael J. Schmeisser, Jens Wiltfang, JeongSeop Rhee, Nils Brose, Holger Taschenberger, and Dilja Krueger-Burg. Functional neuroligin-2-mdga1 interactions differentially regulate synaptic gabaars and cytosolic gephyrin aggregation. Communications Biology, September 2024. URL: http://dx.doi.org/10.1038/s42003-024-06789-z, doi:10.1038/s42003-024-06789-z. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s42003-024-06789-z)

[2. (Connor2016Altered) Steven A. Connor, Ina Ammendrup-Johnsen, Allen W. Chan, Yasushi Kishimoto, Chiaki Murayama, Naokazu Kurihara, Atsushi Tada, Yuan Ge, Hong Lu, Ryan Yan, Jeffrey M. LeDue, Hirotaka Matsumoto, Hiroshi Kiyonari, Yutaka Kirino, Fumio Matsuzaki, Toshiharu Suzuki, Timothy H. Murphy, Yu Tian Wang, Tohru Yamamoto, and Ann Marie Craig. Altered cortical dynamics and cognitive function upon haploinsufficiency of the autism-linked excitatory synaptic suppressor mdga2. Neuron, 91(5):1052–1068, September 2016. URL: http://dx.doi.org/10.1016/j.neuron.2016.08.016, doi:10.1016/j.neuron.2016.08.016. This article has 70 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.neuron.2016.08.016)

[3. (Connor2019Pumping) Steven A Connor, Jonathan Elegheert, Yicheng Xie, and Ann Marie Craig. Pumping the brakes: suppression of synapse development by mdga–neuroligin interactions. Current Opinion in Neurobiology, 57:71–80, August 2019. URL: http://dx.doi.org/10.1016/j.conb.2019.01.002, doi:10.1016/j.conb.2019.01.002. This article has 33 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.conb.2019.01.002)

[4. (Litwack2004Identification) E.David Litwack, Regis Babey, Reto Buser, Matthias Gesemann, and Dennis D.M O’Leary. Identification and characterization of two novel brain-derived immunoglobulin superfamily members with a unique structural organization. Molecular and Cellular Neuroscience, 25(2):263–274, February 2004. URL: http://dx.doi.org/10.1016/j.mcn.2003.10.016, doi:10.1016/j.mcn.2003.10.016. This article has 63 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.mcn.2003.10.016)

[5. (Wang2015MDGA2) Kunning Wang, Qiaoyi Liang, Xiaoxing Li, Ho Tsoi, Jingwan Zhang, Hua Wang, Minnie Y Y Go, Philip W Y Chiu, Enders K W Ng, Joseph J Y Sung, and Jun Yu. Mdga2 is a novel tumour suppressor cooperating with dmap1 in gastric cancer and is associated with disease outcome. Gut, 65(10):1619–1631, July 2015. URL: http://dx.doi.org/10.1136/gutjnl-2015-309276, doi:10.1136/gutjnl-2015-309276. This article has 51 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1136/gutjnl-2015-309276)

6. (Bemben2023Contrasting) Contrasting synaptic roles of MDGA1 and MDGA2. This article has 3 citations.

[7. (Joset2011Rostral) Pascal Joset, Andrin Wacker, Régis Babey, Esther A Ingold, Irwin Andermatt, Esther T Stoeckli, and Matthias Gesemann. Rostral growth of commissural axons requires the cell adhesion molecule mdga2. Neural Development, May 2011. URL: http://dx.doi.org/10.1186/1749-8104-6-22, doi:10.1186/1749-8104-6-22. This article has 25 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/1749-8104-6-22)